Abstract
In the heart, mutations in the TPM1 gene encoding the α-isoform of tropomyosin lead, in particular, to the development of hypertrophic and dilated cardiomyopathies. We compared the effects of hypertrophic, D175N and E180G, and dilated, E40K and E54K, cardiomyopathy mutations in TPM1 gene on the properties of single actin–myosin interactions and the characteristics of the calcium regulation in an ensemble of myosin molecules immobilised on a glass surface and interacting with regulated thin filaments. Previously, we showed that at saturating Ca2+ concentration the presence of Tpm on the actin filament increases the duration of the interaction. Here, we found that the studied Tpm mutations differently affected the duration: the D175N mutation reduced it compared to WT Tpm, while the E180G mutation increased it. Both dilated mutations made the duration of the interaction even shorter than with F-actin. The duration of the attached state of myosin to the thin filament in the optical trap did not correlate to the sliding velocity of thin filaments and its calcium sensitivity in the in vitro motility assay. We suppose that at the level of the molecular ensemble, the cooperative mechanisms prevail in the manifestation of the effects of cardiomyopathy-associated mutations in Tpm.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bai F, Weis A, Takeda AK, Chase PB, Kawai M (2011) Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin’s HCM mutations. Biophys J 100(4):1014–1023. https://doi.org/10.1016/j.bpj.2011.01.001
Bai F, Groth HL, Kawai M (2012) DCM-related tropomyosin mutants E40K/E54K over-inhibit the actomyosin interaction and lead to a decrease in the number of cycling cross-bridges. PLoS ONE 7(10):e47471. https://doi.org/10.1371/journal.pone.0047471
Bai F, Wang L, Kawai M (2013) A study of tropomyosin’s role in cardiac function and disease using thin-filament reconstituted myocardium. J Muscle Res Cell Motil 34:295–310. https://doi.org/10.1007/s10974-013-9343-z
Barua B, Pamula MC, Hitchcock-DeGregori SE (2011) Evolutionarily conserved surface residues constitute actin binding sites of tropomyosin. Proc Natl Acad Sci USA 108:10150–10155. https://doi.org/10.1073/pnas.1101221108
Behrmann E, Müller M, Penczek PA, Mannherz HG, Manstein DJ, Raunser S (2012) Structure of the rigor actin-tropomyosin-myosin complex. Cell 150(2):327–338. https://doi.org/10.1016/j.cell.2012.05.037
Bing W, Redwood CS, Purcell IF, Esposito G, Watkins H, Marston SB (1997) Effects of two hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility. Biochem Biophys Res Commun 236:760–764. https://doi.org/10.1006/bbrc.1997.7045
Bing W, Knott A, Redwood C, Esposito G, Purcell I, Watkins H, Marston S (2000) Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol 32(8):1489–1498. https://doi.org/10.1006/jmcc.2000.1182
Bremel RD, Weber A (1972) Cooperation within actin filament in vertebrate skeletal muscle. Nat New Biol 238(82):97–101
Chang AN, Harada K, Ackerman MJ, Potter JD (2005) Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in α-tropomyosin. J Biol Chem 280:34343–34349. https://doi.org/10.1074/jbc.M505014200
Coviello DA, Maron BJ, Spirito P, Watkins H, Vosberg HP, Thierfelder L, Schoen FJ, Seidman JG, Seidman CE (1997) Clinical features of hypertrophic cardiomyopathy caused by mutation of a “hot spot” in the alpha-tropomyosin gene. J Am Coll Cardiol 29(3):635–640
Desai R, Geeves MA, Kad NM (2015) Using fluorescent myosin to directly visualize cooperative activation of thin filaments. J Biol Chem 290:1915–1925. https://doi.org/10.1074/jbc.M114.609743
Farman GP, Rynkiewicz MJ, Orzechowski M, Lehman W, Moore JR (2018) HCM and DCM cardiomyopathy-linked α-tropomyosin mutations influence off-state stability and crossbridge interaction on thin filaments. Arch Biochem Biophys 647:84–92. https://doi.org/10.1016/j.abb.2018.04.002
Finer JT, Simmons RM, Spudich JA (1994) Single myosin molecule mechanics: piconewton forces and nanometre steps. Nature 368(6467):113–119. https://doi.org/10.1038/368113a0
Fujita H, Sasaki D, Ishiwata S, Kawai M (2002) Elementary steps of the cross-bridge cycle in bovine myocardium with and without regulatory proteins. Biophys J 82(2):915–928. https://doi.org/10.1016/S0006-3495(02)75453-2
Golitsina N, An Y, Greenfield NJ, Thierfelder L, Iizuka K, Seidman JG, Seidman CE, Lehrer SS, Hitchcock-DeGregori SE (1997) Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function. Biochemistry 36:4637–4642. https://doi.org/10.1021/bi962970y
Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80:853–924. https://doi.org/10.1152/physrev.2000.80.2.853
Gupte TM, Haque F, Gangadharan B, Sunitha MS, Mukherjee S, Anandhan S, Rani DS, Mukundan N, Jambekar A, Thangaraj K, Sowdhamini R, Sommese RF, Nag S, Spudich JA, Mercer JA (2015) Mechanistic heterogeneity in contractile properties of α-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies. J Biol Chem 290(11):7003–7015. https://doi.org/10.1074/jbc.M114.596676
Homsher E, Kim B, Bobkova A, Tobacman LS (1996) Calcium regulation of thin filament movement in an in vitro motility assay. Biophys J 70(4):1881–1892. https://doi.org/10.1016/S0006-3495(96)79753-9
Homsher E, Nili M, Chen IY, Tobacman LS (2003) Regulatory proteins alter nucleotide binding to acto-myosin of sliding filaments in motility assays. Biophys J 85(2):1046–1052. https://doi.org/10.1016/S0006-3495(03)74543-3
Ishii S, Suzuki M, Ishiwata S, Kawai M (2019) Functional significance of HCM mutants of tropomyosin, V95A and D175N, studied with in vitro motility assays. Biophys Physicobiol 16:28–40. https://doi.org/10.2142/biophysico.16.0_28
Jagatheesan G, Rajan S, Petrashevskaya N, Schwartz A (2004) Physiological significance of troponin T binding domains in striated muscle tropomyosin. Am J Physiol Heart Circ Physiol 287:1484–1494. https://doi.org/10.1152/ajpheart.01112.2003
Jagatheesan G, Rajan S, Petrashevskaya N, Schwartz A, Boivin G, Arteaga GM, Solaro RJ, Liggett SB, Wieczorek DF (2007) Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. Am J Physiol Heart Circ Physiol 293(2):949–958. https://doi.org/10.1152/ajpheart.01341.2006
Jin JP, Chong SM (2010) Localization of the two tropomyosin-binding sites of troponin T. Arch Biochem Biophys 500:144–150. https://doi.org/10.1016/j.abb.2010.06.001
Kad NM, Kim S, Warshaw DM, VanBuren P, Baker JE (2005) Single-myosin crossbridge interactions with actin filaments regulated by troponin-tropomyosin. Proc Natl Acad Sci USA 102(47):16990–16995. https://doi.org/10.1073/pnas.0506326102
Knight AE, Veigel C, Chambers C, Molloy JE (2001) Analysis of single-molecule mechanical recordings: application to acto-myosin interactions. Prog Biophys Mol Biol 77:45–72. https://doi.org/10.1016/S0079-6107(01)00010-4
Kopylova G, Nabiev S, Nikitina L, Shchepkin D, Bershitsky S (2016a) The properties of the actin-myosin interaction in the heart muscle depend on the isoforms of myosin but not of α-actin. Biochem Biophys Res Commun 476:648–653. https://doi.org/10.1134/S0006297915130106
Kopylova GV, Shchepkin DV, Borovkov DI, Matyushenko AM (2016b) Effect of cardiomyopathic mutations in tropomyosin on calcium regulation of the actin-myosin interaction in skeletal muscle. Bull Exp Biol Med 162(1):42–44. https://doi.org/10.1007/s10517-016-3540-x
Kremneva E, Boussouf S, Nikolaeva O, Maytum R, Geeves MA, Levitsky DI (2004) Effects of two familial hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin. Biophys J 87:3922–3933. https://doi.org/10.1529/biophysj.104.048793
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685. https://doi.org/10.1038/227680a0
Ly S, Lehrer SS (2012) Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin. Biochemistry 51(32):6413–6420. https://doi.org/10.1021/bi3006835
Månsson A, Ušaj M, Moretto L, Rassier DE (2018) Do actomyosin single-molecule mechanics data predict mechanics of contracting muscle? Int J Mol Sci 19(7):E1863. https://doi.org/10.3390/ijms19071863
Margossian SS, Lowey S (1982) Preparation of myosin and its subfragments from rabbit skeletal muscle. Methods Enzymol 85(Pt B):55–71. https://doi.org/10.1016/0076-6879(82)85009-X
Mathur MC, Chase PB, Chalovich JM (2011) Several cardiomyopathy causing mutations on tropomyosin either destabilize the active state of actomyosin or alter the binding properties of tropomyosin. Biochem Biophys Res Commun 406(1):74–78. https://doi.org/10.1016/j.bbrc.2011.01.112
Matyushenko AM, Shchepkin DV, Kopylova GV, Popruga KE, Artemova NV, Pivovarova AV, Bershitsky SY, Levitsky DI (2017) Structural and functional effects of cardiomyopathy-causing mutations in the troponin T-binding region of cardiac tropomyosin. Biochemistry 56:250–259. https://doi.org/10.1021/acs.biochem.6b00994
Matyushenko AM, Koubassova NA, Shchepkin DV, Kopylova GV, Nabiev SR, Nikitina LV, Bershitsky SY, Levitsky DI, Tsaturyan AK (2019) The effects of cardiomyopathy-associated mutations in the head-to-tail overlap junction of α-tropomyosin on its properties and interaction with actin. Int J Biol Macromol 125:1266–1274. https://doi.org/10.1016/j.ijbiomac.2018.09.105
McKillop DFA, Geeves MA (1993) Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J 65:693–701. https://doi.org/10.1016/S0006-3495(93)81110-X
McLachlan AD, Stewart M (1976) The 14-fold periodicity in alpha-tropomyosin and the interaction with actin. J Mol Biol 103(2):271–298. https://doi.org/10.1016/0022-2836(76)90313-2
McLachlan AD, Stewart M, Smillie LB (1975) Sequence repeats in alpha-tropomyosin. J Mol Biol 98:281–291. https://doi.org/10.1016/S0022-2836(75)80118-5
Memo M, Leung MC, Ward DG, dos Remedios C, Morimoto S, Zhang L, Ravenscroft G, McNamara E, Nowak KJ, Marston SB, Messer AE (2013) Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca2+ sensitivity. Cardiovasc Res 99(1):65–73. https://doi.org/10.1093/cvr/cvt071
Mirza M, Marston S, Willott R, Ashley C, Mogensen J, McKenna W, Robinson P, Redwood C, Watkins H (2005) Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 280(31):28498–52806. https://doi.org/10.1074/jbc.M412281200
Mirza M, Robinson P, Kremneva E, Copeland O, Nikolaeva O, Watkins H, Levitsky D, Redwood C, El-Mezgueldi M, Marston S (2007) The effect of mutations in α-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments. J Biol Chem 282:13487–13497. https://doi.org/10.1074/jbc.M701071200
Monteiro PB, Lataro RC, Ferro JA, Reinach FC (1994) Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. J Biol Chem 269:10461–10466
Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wieczorek DF (1999) Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ Res 85(1):47–56. https://doi.org/10.1161/01.RES.85.1.47
Olson TM, Kishimoto NY, Whitby FG, Michels VV (2001) Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 33(4):723–732. https://doi.org/10.1006/jmcc.2000.1339
Orzechowski M, Fischer S, Moore JR, Lehman W, Farman GP (2014) Energy landscapes reveal the myopathic effects of tropomyosin mutations. Arch Biochem Biophys 564:89–99. https://doi.org/10.1016/j.abb.2014.09.007
Palmiter KA, Tyska MJ, Dupuis DE, Alpert NR, Warshaw DM (1999) Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms. J Physiol 519(3):669–678. https://doi.org/10.1111/j.1469-7793.1999.0669n.x
Pardee JD, Spudich JA (1982) Purification of muscle actin. Methods Enzymol 85(Pt B):164–179. https://doi.org/10.1016/0076-6879(82)85020-9
Potter JD (1982) Preparation of troponin and its subuits. Methods Enzymol 85(Pt B):241–263. https://doi.org/10.1016/0076-6879(82)85024-6
Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro JR, Wieczorek DF (2001) A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 33:1815–1828. https://doi.org/10.1006/jmcc.2001.1445
Rajan S, Ahmed RP, Jagatheesan G, Petrashevskaya N, Boivin GP, Urboniene D, Arteaga GM, Wolska BM, Solaro RJ, Liggett SB, Wieczorek DF (2007) Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 101(2):205–214. https://doi.org/10.1161/CIRCRESAHA.107.148379
Redwood C, Robinson P (2013) Alpha-tropomyosin mutations in inherited cardiomyopathies. J Muscle Res Cell Motil 34(3–4):285–294. https://doi.org/10.1007/s10974-013-9358-5
Shchepkin DV, Nabiev SR, Kopylova GV, Matyushenko AM, Levitsky DI, Bershitsky SY, Tsaturyan AK (2017) Cooperativity of myosin interaction with thin filaments is enhanced by stabilizing substitutions in tropomyosin. J Muscle Res Cell Motil 38(2):183–191. https://doi.org/10.1007/s10974-017-9472-x
Talmadge RJ, Roy RR (1993) Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoform. J Appl Physiol 75:2337–2340. https://doi.org/10.1152/jappl.1993.75.5.2337
Thierfelder L, MacRae C, Watkins H, Tomfohrde J et al (1993) A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 90(13):6270–6274
Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE (1994) Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77(5):701–712. https://doi.org/10.1016/0092-8674(94)90054-X
Tyska MJ, Warshaw DM (2002) The myosin power stroke. Cell Motil Cytoskelet 51:1–15. https://doi.org/10.1002/cm.10014
Wang F, Brunet NM, Grubich JR, Bienkiewicz EA, Asbury TM, Compton LA, Mihajlović G, Miller VF, Chase PB (2011) Facilitated cross-bridge interactions with thin filaments by familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin. J Biomed Biotechnol 2011:435271. https://doi.org/10.1155/2011/435271
Watkins H, Ashrafian H, Redwood C (2011) Inherited cardiomyopathies. N Engl J Med 364:1643–1656. https://doi.org/10.1056/NEJMra0902923
Webb M, del Jackson R Jr, Stewart TJ, Dugan SP, Carter MS, Cremo CR, Baker JE (2013) The myosin duty ratio tunes the calcium sensitivity and cooperative activation of the thin filament. Biochemistry 52(37):6437–6444
Wernicke D, Thiel C, Duja-Isac CM, Essin KV, Spindler M, Nunez DJ, Plehm R, Wessel N, Hammes A, Edwards RJ, Lippoldt A, Zacharias U, Strömer H, Neubauer S, Davies MJ, Morano I, Thierfelder L (2004) alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways. Am J Physiol Regul Integr Comp Physiol 287(3):R685–R695. https://doi.org/10.1152/ajpregu.00620.2003
Williams DL Jr, Greene LE (1983) Comparison of the effects of tropomyosin and troponin-tropomyosin on the binding of myosin subfragment 1 to actin. Biochemistry 22(11):2770–2774. https://doi.org/10.1021/bi00280a027
Yamashita H, Sugiura S, Fujita H, Si Yasuda, Nagai R, Saeki Y, Sunagawa K, Sugi H (2003) Myosin light chain isoforms modify force-generating ability of cardiac myosin by changing the kinetics of actin-myosin interaction. Cardiovasc Res 60:580–588. https://doi.org/10.1016/j.cardiores.2003.09.011
Acknowledgements
The authors thank Mr. D.I. Borovkov for assistance in processing the optical trap data.
Funding
This work was funded by the Russian Foundation for Basic Research Grants 17-00-00065 (D.L.), 17-00-00070 (S.B.), 17-00-00066 (N.K.), and 18-015-00252 (G.K.); and State Program AAAA-A19-119010590010-3 (D.L.) and AAAA-A18-118020590135-3 (S.B.). This work was performed using the equipment of the Shared Research Center of Scientific Equipment of IIP UB RAS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kopylova, G.V., Shchepkin, D.V., Nabiev, S.R. et al. Cardiomyopathy-associated mutations in tropomyosin differently affect actin–myosin interaction at single-molecule and ensemble levels. J Muscle Res Cell Motil 40, 299–308 (2019). https://doi.org/10.1007/s10974-019-09560-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10974-019-09560-8